Skip to main content

Table 1 Baseline characteristics of study participants who were started on HAART in the period between 2004 and 2013

From: Forecast analysis of any opportunistic infection among HIV positive individuals on antiretroviral therapy in Uganda

Variable

Total

Female

Male

p-value

Gender (36,133), n(%)

 Female

23,767(66)

-

-

-

 Male

12,366(34)

   

Median age(36,120), n(IQR)

33(27–40)

32(26–39)

36(29–43)

<0.0001

Age (36,120), n(%)

 <35 years

19,338 (54)

13,894 (58)

5444 (44)

<0.0001

 >=35 years

16,782 (46)

9863 (42)

6919 (56)

 

Location (36,133), n(%)

 Eastern

9793(27)

6271 (26)

3522(28)

<0.0001

 Central

9493(26)

6573(28)

2920(24)

 

 Western

8576(24)

5426(23)

3150(25)

 

 Northern

8271(23)

5497(23)

2774(23)

 

Education (n = 34,337), n(%)

 Primary/none

26,331(77)

18,165(81)

8166(69)

<0.0001

 >=Secondary

8006(23)

4342(19)

3664(31)

 

Marital status (n = 34,338), n(%)

 Single/never married

2148(6)

1260(6)

888(7)

<0.0001

 Married

17,187(50)

9523(42)

7664(65)

 

 Divorced

5778(17)

4342(19)

1436(12)

 

 Widowed

6932(20)

6118(27)

814(7)

 

 others

2293(7)

1254(6)

1039(9)

 

Occupation (n = 33,454), n(%)

 Paid employee

5731(17)

2611(12)

3120(27)

<0.0001

 Self employed

12,157(36)

9193(42)

2964(26)

 

 Subsistence farmer

13,283(40)

8855(40)

4428(38)

 

 others

2283(7)

1196(6)

1087(9)

 

WHO clinical stage (n = 36, 133), n(%)

 I&II

16,535 (28.5)

11,030 (28.5)

5505 (28.6)

0.773

 III&IV

41,410 (71.5)

27,675 (71.5)

13,735 (71.4)

 

Weight (23,848), n(%)

 <55 years

11,853(50)

8156(52)

3697(45)

<0.0001

 >=55 years

11,995(50)

7466(48)

3697(55)

 

ART regimes

 Stavudine

3926(11)

2743(11)

1183(10)

 

 Zidovudine

18,142(50)

11,881(50)

6261(50)

<0.0001

 Tenofovir

9931(28)

6397(27)

3534(29)

 

 Other

4134(11)

2746(12)

1388(11)

 

Year of enrolment on HAART

 2004–2008

12,433(34)

8439(36)

3994(32)

<0.0001

 2009–2013

23,700(66)

15,328(64)

8372(68)